StockData

Seaport Therapeutics, Inc. (SPTX) company profile

SPTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026
$18.17−0.95 (-4.97%)

Close on Nov 17, 2026Market cap $972.65MP/E –Yield –

About Seaport Therapeutics

Pharmaceutical Preparations, SIC 2834

Seaport Therapeutics, Inc. is listed on Nasdaq under the ticker SPTX, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.

Company profile

Company

Legal name
Seaport Therapeutics, Inc.
Headquarters
Boston, MA
Address
6 Tide Street, Suite 400 02110
Phone
(617) 807-4062
Industry
Pharmaceutical Preparations
Incorporated in
Delaware
Fiscal year ends
December 31

Stock & identifiers

Ticker
SPTX
Exchange
Nasdaq
IPO date
May 1, 2026
Shares outstanding
54M, Jul 27, 2026
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
2042347
CUSIP
81221K108
ISIN
US81221K1088
FIGI
BBG01MBY86J1
Share class FIGI
BBG01MBY86L8
EIN
99-2235719

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Daphne ZoharChief Executive Officer, Director1,094,001
Lana GladsteinGeneral Counsel33,515
Michael Cunyuan ChenChief Scientific Officer3,351
Lauren WhiteChief Financial Officer6,702
Antony LoebelChief Medical Officer20,109
Denice TorresDirector18,406
Robert J. HombachDirector13,000
General Atlantic (SP), L.P.Director–
Gap Coinvestments Iii, LlcDirector–
General Atlantic, L.P.Director–
GAP Coinvestments CDA, L.P.Director–
Gap Coinvestments Iv, LlcDirector–
(Bermuda) L.P. GAPDirector–
General Atlantic Genpar (Bermuda), L.P.Director–
General Atlantic Genpar, L.P.Director–
GAP Coinvestments V, LLCDirector–
General Atlantic (SPV) GP, LLCDirector6,101,582
Atlantic GenPar (Lux) SCSp GeneralDirector6,101,582
General Atlantic Partners (Lux), SCSpDirector–
General Atlantic Partners 100, L.P.Director–
Atlantic (Lux) S.a r.l. GeneralDirector–
James HealyDirector1,927,159
Sharon MatesDirector–
Steven M. PaulDirector863,031
David E. WheadonDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
May 1, 2026
Offer price
$18.00
Securities offered
14,160,000
Gross proceeds
$254.88M
Exchange
Nasdaq
First trading day
May 1, 2026
First-day close
$19.84+10.2%
Lock-up ends (est.)
Oct 28, 2026

“The initial public offering price is $18.00 per share.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Corporate history

Events identified from SEC filings

See a number that looks wrong?